New Study: ciprofloxacin
244 treatment packs of the broad spectrum antibiotic ciprofloxacin were sampled from a stratified sample of 61 web pharmacies. Each sample was analyzed for active pharmaceutical ingredient content (API) and 11 (4.5%) were found to be grossly (less than 80%) under content. Most of the 11 came from non-certified sites, but two came from certified sites. None of the failures appeared to be a falsified medicine (packaging appeared correct and contained over 50% API). All failures were made by Asian manufacturers (7 Indian and 4 Chinese). All the failures regardless of source are a risk to patient health, and could accelerate population level resistance to this crucial antibiotic.